212 related articles for article (PubMed ID: 23536193)
1. Suppression of osteoclastogenesis through phosphorylation of eukaryotic translation initiation factor 2 alpha.
Hamamura K; Tanjung N; Yokota H
J Bone Miner Metab; 2013 Nov; 31(6):618-28. PubMed ID: 23536193
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in silico analysis of an inhibitory mechanism of osteoclastogenesis by salubrinal and guanabenz.
Hamamura K; Chen A; Tanjung N; Takigawa S; Sudo A; Yokota H
Cell Signal; 2015 Feb; 27(2):353-62. PubMed ID: 25435425
[TBL] [Abstract][Full Text] [Related]
3. Osteoporosis regulation by salubrinal through eIF2α mediated differentiation of osteoclast and osteoblast.
He L; Lee J; Jang JH; Sakchaisri K; Hwang J; Cha-Molstad HJ; Kim KA; Ryoo IJ; Lee HG; Kim SO; Soung NK; Lee KS; Kwon YT; Erikson RL; Ahn JS; Kim BY
Cell Signal; 2013 Feb; 25(2):552-60. PubMed ID: 23178987
[TBL] [Abstract][Full Text] [Related]
4. eIF2α signaling regulates autophagy of osteoblasts and the development of osteoclasts in OVX mice.
Li J; Li X; Liu D; Hamamura K; Wan Q; Na S; Yokota H; Zhang P
Cell Death Dis; 2019 Dec; 10(12):921. PubMed ID: 31801950
[TBL] [Abstract][Full Text] [Related]
5. Role of endoplasmic reticulum stress in disuse osteoporosis.
Li J; Yang S; Li X; Liu D; Wang Z; Guo J; Tan N; Gao Z; Zhao X; Zhang J; Gou F; Yokota H; Zhang P
Bone; 2017 Apr; 97():2-14. PubMed ID: 27989543
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of osteoblastogenesis and suppression of osteoclastogenesis by inhibition of de-phosphorylation of eukaryotic translation initiation factor 2 alpha.
Hamamura K; Chen A; Yokota H
Receptors Clin Investig; 2015; 2(1):. PubMed ID: 26005701
[TBL] [Abstract][Full Text] [Related]
7. Endoplasmic reticulum stress response mediated by the PERK-eIF2(alpha)-ATF4 pathway is involved in osteoblast differentiation induced by BMP2.
Saito A; Ochiai K; Kondo S; Tsumagari K; Murakami T; Cavener DR; Imaizumi K
J Biol Chem; 2011 Feb; 286(6):4809-18. PubMed ID: 21135100
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of malignant phenotypes of breast cancer cells through eIF2α-mediated downregulation of Rac1 signaling.
Hamamura K; Minami K; Tanjung N; Wan Q; Koizumi M; Matsuura N; Na S; Yokota H
Int J Oncol; 2014 Jun; 44(6):1980-8. PubMed ID: 24691491
[TBL] [Abstract][Full Text] [Related]
9. The PERK-EIF2α-ATF4 signaling branch regulates osteoblast differentiation and proliferation by PTH.
Zhang K; Wang M; Li Y; Li C; Tang S; Qu X; Feng N; Wu Y
Am J Physiol Endocrinol Metab; 2019 Apr; 316(4):E590-E604. PubMed ID: 30668150
[TBL] [Abstract][Full Text] [Related]
10. Sevoflurane-Induced Endoplasmic Reticulum Stress Contributes to Neuroapoptosis and BACE-1 Expression in the Developing Brain: The Role of eIF2α.
Liu B; Xia J; Chen Y; Zhang J
Neurotox Res; 2017 Feb; 31(2):218-229. PubMed ID: 27682474
[TBL] [Abstract][Full Text] [Related]
11. PERK-eIF2α-ATF4 pathway mediated by endoplasmic reticulum stress response is involved in osteodifferentiation of human periodontal ligament cells under cyclic mechanical force.
Yang SY; Wei FL; Hu LH; Wang CL
Cell Signal; 2016 Aug; 28(8):880-6. PubMed ID: 27079961
[TBL] [Abstract][Full Text] [Related]
12. Effects of salubrinal on development of osteoclasts and osteoblasts from bone marrow-derived cells.
Yokota H; Hamamura K; Chen A; Dodge TR; Tanjung N; Abedinpoor A; Zhang P
BMC Musculoskelet Disord; 2013 Jul; 14():197. PubMed ID: 23816340
[TBL] [Abstract][Full Text] [Related]
13. Coenzyme q10 regulates osteoclast and osteoblast differentiation.
Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK
J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186
[TBL] [Abstract][Full Text] [Related]
14. Salubrinal promotes healing of surgical wounds in rat femurs.
Zhang P; Hamamura K; Jiang C; Zhao L; Yokota H
J Bone Miner Metab; 2012 Sep; 30(5):568-79. PubMed ID: 22610062
[TBL] [Abstract][Full Text] [Related]
15. Synergistic apoptosis induction in leukemic cells by the phosphatase inhibitor salubrinal and proteasome inhibitors.
Drexler HC
PLoS One; 2009; 4(1):e4161. PubMed ID: 19129918
[TBL] [Abstract][Full Text] [Related]
16. Predicting and validating the pathway of Wnt3a-driven suppression of osteoclastogenesis.
Hamamura K; Chen A; Nishimura A; Tanjung N; Sudo A; Yokota H
Cell Signal; 2014 Nov; 26(11):2358-69. PubMed ID: 25038457
[TBL] [Abstract][Full Text] [Related]
17. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
18. Agelasine D suppresses RANKL-induced osteoclastogenesis via down-regulation of c-Fos, NFATc1 and NF-κB.
Kang MR; Jo SA; Yoon YD; Park KH; Oh SJ; Yun J; Lee CW; Nam KH; Kim Y; Han SB; Yu J; Rho J; Kang JS
Mar Drugs; 2014 Nov; 12(11):5643-56. PubMed ID: 25421321
[TBL] [Abstract][Full Text] [Related]
19. Experimental Evidence Shows Salubrinal, an eIF2α Dephosphorylation Inhibitor, Reduces Xenotoxicant-Induced Cellular Damage.
Matsuoka M; Komoike Y
Int J Mol Sci; 2015 Jul; 16(7):16275-87. PubMed ID: 26193263
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of matrix metalloproteinase-9 activity by doxycycline ameliorates RANK ligand-induced osteoclast differentiation in vitro and in vivo.
Franco GC; Kajiya M; Nakanishi T; Ohta K; Rosalen PL; Groppo FC; Ernst CW; Boyesen JL; Bartlett JD; Stashenko P; Taubman MA; Kawai T
Exp Cell Res; 2011 Jun; 317(10):1454-64. PubMed ID: 21420951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
